Mesylate (the active ingredient)
Treatment of hyperprolactinemia (high levels of prolactin in the blood)
Management of Parkinson's disease (as adjunctive therapy)
Treatment of prolactinomas (prolactinsecreting pituitary tumors)
Suppression of lactation (milk production)
Olocrypt 2.5mg Tab (Bromocriptine) is a dopamine agonist. It works by stimulating dopamine receptors in the brain, thereby inhibiting the release of prolactin from the pituitary gland. In Parkinson's disease, it helps to alleviate symptoms by mimicking the actions of dopamine.
Store at room temperature, away from moisture and direct sunlight. Keep out of reach of children. Discard any unused medication after the expiration date.
Dosage varies depending on the condition being treated and the individual patient's response. Always follow your doctor's instructions.
It is typically taken orally, with or without food.
Start with a low dose and gradually increase as directed by your physician.
Missed doses should be taken as soon as remembered, unless it is nearly time for the next dose. Do not double the dose.
Nausea
Vomiting
Headache
Dizziness
Fatigue
Nasal congestion
Constipation
Hallucinations (rare)
Psychiatric disturbances (rare)
Cardiovascular effects (rare)
Alcohol can enhance the sedative effects of bromocriptine and increase the risk of side effects. Avoid excessive alcohol consumption while taking this medication.
Bromocriptine can cause dizziness and drowsiness. Avoid driving or operating machinery until you know how this medication affects you.
Bromocriptine is generally not recommended during pregnancy or breastfeeding due to potential risks to the fetus or infant. Consult your doctor immediately.
Safety and efficacy in children have not been established. Not recommended for use in pediatric populations.
Caution is advised in patients with impaired kidney function. Dosage adjustments may be necessary.
Caution is advised in patients with impaired liver function. Dosage adjustments may be necessary.
Consult your doctor or pharmacist for more detailed information and up-to-date prescribing information.
Refer to the official drug monograph for detailed information on the drug.
